SC files charges against AUF MBZ founder


The Securities Commission of Malaysia building in Kuala Lumpur

PETALING JAYA: The Securities Commission (SC) has charged AUF MBZ Consortium PLT founder Datuk Wira Mahadi Badrul Zaman at the Kuala Lumpur Sessions Court with two counts of conducting unlicensed capital market activities.

The charges were brought under Section 58(1) of the Capital Markets and Services Act 2007 (CMSA), the regulator said in a statement.

“The charges were in relation to AUF MBZ’s conduct of carrying on a business of dealing in securities without a Capital Markets Services Licence issued by the SC.

“Mahadi, who is also a partner of AUF MBZ, is deemed to have committed the offences which occurred between June 14, 2021, to Aug 9, 2023, (the first charge) and between Sept 3, 2021, to Feb 15, 2024, (the second charge) in Selangor under section 367(1) of the CMSA.

Mahadi claimed trial to both charges, which were read out in two separate courts.

Separately, Tan Sri Mohd Daud Bakar, a former director of unlisted public company Energy Eco Bhd (EEB), was charged with one count of abetment under section 58(1), read together with section 370(c) of the CMSA.

The charge relates to EEB’s alleged abetment of AUF MBZ in committing the offence under the first charge.

Daud, who was a representative of EEB at the material time, is deemed to have committed the offence under section 367(1) of the CMSA. Daud also claimed trial.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Ringgit opens firmer against US$, major currencie
Traders await results, major banks expected to report
Trading ideas: Orkim, Seni Jaya, AirAsia X, PetDag, PetGas, Solarvest, Unisem, IOI, MR DIY, Frontken, Oriental Kopi, LPI, Majuperak
Orkim wins RM32mil contract
Solarvest delivers strong 3Q as net profit jumps 46% to RM21mil
IOI Corp’s quarterly profit quadruples
Radium diversifies into healthcare
Oriental Kopi 1Q earnings surge 30%
LPI Capital posts lower FY25 earnings
SLP’s medical push to drive 42% profit growth in FY26

Others Also Read